Brief: Akero Therapeutics Anticipates Cash, Cash Equivalents And Short-Term Marketable Securities Of About $660 Million As Of June 2
June 5 (Reuters) - Akero Therapeutics Inc AKRO.O :
* AKERO THERAPEUTICS INC - CURRENTLY ANTICIPATES THAT ITS
CASH,
CASH EQUIVALENTS AND SHORT-TERM MARKETABLE SECURITIES WERE ABOUT
$660 MILLION AS OF JUNE 2
Further company coverage: AKRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk